Transanal minimally invasive surgery for benign and malignant rectal neoplasia - 14/08/14
, Lynn A. Weston, M.D. b, Alisa M. Coker, M.D. a, Garth R. Jacobsen, M.D. a, Mark A. Talamini, M.D. a, Santiago Horgan, M.D. a, Sonia L. Ramamoorthy, M.D. aAbstract |
Background |
Transanal minimally invasive surgery (TAMIS), an alternative technique to transanal endoscopic microsurgery, was developed in 2009. Herein, we describe our initial experience using TAMIS for benign and malignant rectal neoplasia.
Methods |
This is an institutional review board approved, retrospective case series report.
Results |
TAMIS was performed in 32 patients for rectal adenoma (13), adenocarcinoma (16), and carcinoid (3). There were 14 women, with mean age 62 ± 15 years and body mass index 28 ± 5 kg/m2. Lesion size ranged from .5 to 8.5 cm, distance from the dentate line 1 to 11 cm, and circumference of the lesion 10% to 100%. The mean operative time was 123 ± 62 minutes. Mean hospital length of stay was 2.5 ± 2 days. Complications included urinary tract infection (1), Clostridium difficile diarrhea (1), atrial fibrillation (1), rectal stenosis (1), and rectal bleeding (1).
Conclusion |
TAMIS using a disposable transanal access platform is a safe and effective method to remove rectal lesions in this case series.
Le texte complet de cet article est disponible en PDF.Keywords : Transanal minimally invasive surgery, Transanal endoscopic microsurgery, Rectal Mass, Endoscope, Rectal cancer, Rectal adenoma, Rectal carcinoid
Plan
| Lynn A. Weston and Alisa M. Coker declare no conflicts of interest. |
|
| Disclosures: Elisabeth C. McLemore, M.D., is a consultant and an instructor for industry-sponsored educational events for Applied Medical and Ethicon Endosurgery. Dr McLemore is a consultant for Covidien. |
|
| Lynn A. Weston, M.D., has no financial ties to disclose. |
|
| Alisa M. Coker, M.D., has no financial ties to disclose. Dr Coker is a minimally invasive surgery research resident under the mentorship of Drs Horgan, Talamini, Ramamoorthy, and McLemore. |
|
| Garth R. Jacobsen, M.D., is a consultant and an instructor for industry-sponsored educational events for Ethicon Endosurgery. |
|
| Mark A. Talamini, M.D., serves on the advisory board and is a consultant for Olympus. Dr Talamini is also a consultant and an instructor for industry-sponsored educational events for Ethicon Endosurgery. Educational grants from Ethicon Endosurgery and Olympus provide additional funding to support research, education, and training conducted at the UC San Diego Center for the Future of Surgery. |
|
| Santiago Horgan, M.D., serves on the advisory board and is a consultant for Olympus. Dr Horgan is also a consultant and an instructor for industry-sponsored educational events for Ethicon Endosurgery. Educational grants from Ethicon Endosurgery and Olympus provide additional funding to support research, education, and training conducted at the UC San Diego Center for the Future of Surgery. |
|
| Sonia L. Ramamoorthy, M.D., is a consultant and an instructor for industry-sponsored educational events for Applied Medical and Ethicon Endosurgery. |
Vol 208 - N° 3
P. 372-381 - septembre 2014 Retour au numéro
Article précédent
- Intracranial pressure versus cerebral perfusion pressure as a marker of outcomes in severe head injury: a prospective evaluation
- Efstathios Karamanos, Pedro G. Teixeira, Emre Sivrikoz, Stephen Varga, Konstantinos Chouliaras, Obi Okoye, Peter Hammer
- The evaluation of national time trends, quality of care, and factors affecting the use of minimally invasive breast biopsy and open biopsy for diagnosis of breast lesions
- Linda Adepoju, Weikai Qu, Vivian Kazan, Munier Nazzal, Mallory Williams, Joseph Sferra
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?